Role of immunoregulatory donor T cells in suppression of graft-versus- host disease following donor leukocyte infusion therapy

Journal of Immunology

Volumn 163, Issue 12, 1999, Pages 6479-6487

  Johnson, Bryon D ^a   Becker, Emily E ^a   LaBelle, James L ^a   Truitt, Robert L ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFUSION; MOUSE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, THY-1; CELL DIFFERENTIATION; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; IMMUNOPHENOTYPING; ISOANTIBODIES; LEUKOCYTE TRANSFUSION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED AKR; MICE, INBRED C57BL; MICE, KNOCKOUT; RADIATION CHIMERA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; THYMUS GLAND;

EID: 0032741541     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Kolb, H. J., A. Schattenberg, J. M. Goldman, B. Hertenstein, N. Jacobsen, W. Arcese, P. Ljungman, A. Ferrant, L. Verdonck, D. Niederwieser, et al. 1995. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86:2041.
2. Slavin, S., E. Naparstek, A. Nagler, A. Ackerstein, S. Samuel, J. Kapelushnik, C. Brautbar, and R. Or. 1996. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 87:2195.
3. Collins, R. H., O. Shpilberg, W. R. Drobyski, D. L. Porter, S. Giralt, R. Champlin, S. A. Goodman, S. N. Wolff, W. Hu, C. Verfaillie, et al. 1997. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogencic bone marrow transplantation. J. Clin. Oncol. 15:433.
4. Johnson, B. D., and R. L. Truitt. 1995. Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance and allows for persistent antileukemic reactivity without severe graft-versus-host disease. Blood 85:3302.
5. Antin, J., and J. Ferrara. 1992. Cylokine dysregulation and acute graft-versus-host disease. Blood 80:2964.
6. Ferrara, J., S. Abhyankar, and D. Gilliland. 1993. Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1. Transpl. Proc. 25:1216.
7. Hill, G. R., J. M. Crawford, K. R. Cooke, Y. S. Brinson, L. Pan, and J. L. M. Ferrara. 1997. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 90:3204.
8. Shlomchik, W. D., M. S. Couzens, C. B. Tang, J. McNiff, M. E. Robert, J. Liu, M. J. Shlomchik, and S. G. Emerson. 1999. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285:412.
9. Tutschka, P. J., P. F. Ki, W. E. Beschorner, A. D. Hess, and G. W. Santos. 1981. Suppressor cells in transplantation tolerance. II. Maturation of suppressor cells in the bone marrow chimera. Transplantation 32:321.
10. Tutschka, P. J., A. D. Hess, W. E. Beschorner, and G. W. Santos. 1981. Suppressor cells in transplantation tolerance. I. Suppressor cells in the mechanism of tolerance in radiation chimeras. Transplantation 32:203.
11. Tutschka, P. J., A. D. Hess, W. E. Beschorner, and G. W. Santos. 1982. Suppressor cells in transplantation tolerance. III. The role of antigen in the maintenance of transplantation tolerance. Transplantation 33:510.
12. Shih, C. Y., and R. L. Truitt. 1987. Prophylaxis of graft-vs-host disease by adoptive transfer of a class II antigen-specific murine T-cell clone. In Cellular Immunotherapy of Cancer. R. L. Truitt, R. P. Gale, and M. M. Bortin, eds. Alan R. Liss, New York, p. 439.
13. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614.
14. Johnson, B. D., W. R. Drobyski, and R. L. Truitt. 1993. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Bone Marrow Transplant. 11:329.
15. Johnson, B. D., E. E. Becker, and R. L. Truitt. 1999. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets. Biol. Blood Marrow Transplant. 5:123.
16. Mombaerts, P., A. R. Clarke, M. A. Rudnicki, J. Iacomini, S. Itohara, J. J. Lafaille, L. Wang, Y. Ichikawa, R. Jaenisch, M. L. Hooper, et al. 1992. Mutations in T-cell antigen receptor genes α and β block thymocyte development at different stages. Nature 360:225.
17. Bemelman, F., K. Honey, E. Adams, S. Cobbold, and H. Waldmann. 1998. Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose. J. Immunol. 160:2645.
18. Yin, D., and C. G. Fathman. 1995. CD4-positive suppressor cells block allotransplant rejection. J. Immunol. 154:6339.
19. Qin, S., S. P. Cobbold, H. Pope, J. Elliott, D. Kioussis, J. Davies, and H. Waldmann. 1993. "Infectious" transplantation tolerance. Science 259:974.
20. Modigliani, Y., A. Cuntinho, P. Pereira, D. L. Douarin, V. Thomas-Vaslin, O. Burlen-Defranoux, J. Salaun, and A. Bandeira. 1996. Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium. Eur. J. Immunol. 26:1807.
21. Saoudi, A., B. Seddon, V. Heath, D. Fowell, and D. Mason. 1996. The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T cell subset. Immunol. Rev. 149:195.
22. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287.
23. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162:5317.
24. Boitard, C., R. Yasunami, M. Dardenne, and J. F. Bach. 1989. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 169:1669.
25. Smith, H., Y. Sakamoto, K. Kasai, and K. S. K. Tung. 1991. Effector and regulatory cells in autoimmune oophoritis elicited by neonatal thymectomy. J. Immunol. 147:2928.
26. Asano, M., M. Toda, N. Sakaguchi, and S. Sakaguchi. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184:387.
27. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160:1212.
28. Fischer, A. C., W. E. Beschorner, and A. D. Hess. 1989. Requirements for the induction and adoptive transfer of cyclosporine-induced syngeneic graft-vs-host disease. J. Exp. Med. 169:1031.
29. Hess, A. D., A. C. Fischer, and L. R. Horwitz. 1993. Cyclosporine-induced autoimmunity: critical role of autoregulation in the prevention of major histocompatibiltiy class II-dependent autoaggression. Transplant. Proc. 25:2811.
30. Wu, D. Y., and I. Goldschneider. 1999. Cyclosporin A-induced autologous graft-versus-host disease: a prototypical model of autoimmunity and active (dominant) tolerance coordinately induced by recent thymic emigrants. J. Immunol. 162: 6929.
31. Modigliani, Y., P. Pereira, V. Thomas-Vaslin, J. Salaun, O. Burlen-Defranoux, A. Coutinho, N. L. Douarin, and A. Bandeira. 1995. Regulatory T cells in thymic epithelium-induced tolerance. I. Suppression of mature peripheral non-tolerant T cells. Eur. J. Immunol. 25:2563.
32. Modigliani, Y., A. Bandeira, and A. Coutinho. 1996. A model for developmentally acquired thymus-dependent tolerance to central and peripheral antigens. Immunol. Rev. 149:155.
33. -CD8) α/β T cell receptor-bearing cells. J. Immunol. 145:4046.
34. -CD8 cell population. J. Immunol. 148:3746.
35. +) T cell which promote tolerance induction and regulate autoimmunity. Immunol. Rev. 149:217.
36. + cell lines. Cell. Immunol. 129:478.
37. +) T cells established from murine tumor-infiltrating lymphocytes. J. Immunol. 158:4846.
38. Weisdorf, D., R. Hakke, B. Blazar, W. Miller, P. McGlave, N. Ramsay, J. Kersey, and A. Filipovich. 1991. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 51:1197.
39. Bryson, J. S., C. D. Jennings, B. E. Caywood, A. R. Dix, D. M. Lowery, and A. M. Kaplan. 1997. Enhanced graft-versus-host disease in older recipient mice following allogeneic bone marrow transplantation. Bone Marrow Transplant. 19:721.